CircANKRD36 Knockdown Inhibits M1 Polarization and Inflammatory Response via miR-498/TXNRD1 in LPS-Stimulated

Zhimao Ye1,2, Cuiping Li1,2, Hao Li1,2

  • 1Department of Prosthodontics, College & Affiliated Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi, China.

Insights

High glucose promotes macrophage M1 polarization and inflammation via circANKRD36. Knocking down circANKRD36 inhibits this response by targeting the miR-498/TXNRD1 axis, offering a potential therapeutic strategy for diabetic bone healing.

Area of Science:

  • Immunology
  • Molecular Biology
  • Endocrinology

Background:

  • Macrophage polarization and inflammation are critical in diabetic bone healing disorders.
  • High glucose conditions exacerbate these processes, impacting immune cell function.

Purpose of the Study:

  • To investigate the role and mechanism of circular RNA ANKRD36 (circANKRD36) in M1 macrophage polarization and inflammation under high glucose conditions.
  • To elucidate the regulatory pathway involving circANKRD36, microRNA-498 (miR-498), and thioredoxin reductase 1 (TXNRD1).

Main Methods:

  • Stimulation of macrophages with lipopolysaccharide (LPS) under high glucose conditions.
  • Assessment of M1 polarization markers (CD11b, CD86) and pro-inflammatory cytokines (IL-1β, TNF-α, iNOS).
  • circANKRD36 and miR-498 expression analysis, interaction validation (luciferin assay), and knockdown/overexpression experiments.
  • High-throughput mRNA sequencing and bioinformatic analysis to identify signaling pathways and target genes.
  • Validation of TXNRD1 as a downstream target.

Main Results:

  • High glucose increased circANKRD36 expression and M1 polarization markers while decreasing miR-498.
  • circANKRD36 knockdown suppressed M1 polarization and inflammation; miR-498 knockdown reversed these effects.
  • circANKRD36 regulates M1 polarization via the miR-498/TXNRD1 axis, impacting AGE-RAGE, NF-κB, MAPK, and TNF signaling pathways.

Conclusions:

  • circANKRD36 promotes M1 polarization and inflammation in macrophages under high glucose conditions.
  • circANKRD36 knockdown inhibits this response through the miR-498/TXNRD1 pathway.
  • Targeting circANKRD36 offers a potential therapeutic avenue for diabetic bone complications.

Related Concept Videos